• 

  May 8, 2026

  restor3d’s Aeros Ankle System Goes Full Commercial, 3D-Printed Orthopaedics Hits the Clinic

  R.D. Solorzano

• 

  May 7, 2026

  Miromatrix’s miroliverELAP Earns RMAT Designation

  R.D. Solorzano

• 

  April 30, 2026

  Eli Lilly Pays Up to $7B for Kelonia’s In Vivo CAR-T Platform and What It Means for Cell Therapy Manufacturing

  R.D. Solorzano

• 

  April 21, 2026

  ARPA-H Is Funding the Regeneration of Human Joints, and the Biofabrication Implications Go Further Than Osteoarthritis

  R.D. Solorzano

• 

  April 8, 2026

  Cellbricks Therapeutics Raises €10M to Advance Biofabricated Tissue Implants for Wound Care and Reconstructive Surgery

  R.D. Solorzano

• 

  April 5, 2026

  Canada Just Bet Another $280M on Bioprinted Medicines, Here’s What It Means for the Industry

  R.D. Solorzano

• 

  March 8, 2026

  UC San Diego’s ARPA-H Project Targets the A Different Approach for the Bioprinted LIVER Program

  R.D. Solorzano

• 

  March 6, 2026

  Japan Moves Toward First Commercial iPS Cell Therapies

  R.D. Solorzano

• 

  March 3, 2026

  Cellares Raises $257M to Industrialize Cell Therapy Manufacturing

  R.D. Solorzano

• 

  February 20, 2026

  United Therapeutics Reports Breakthrough Phase 1 Results for Bioengineered Liver Support System

  R.D. Solorzano